Florida Senate
-
2026
CS for CS for SB 1758
By
the CommitteeCommittees on Appropriations; and Health Policy; and Senators Gaetz and
Brodeur
Senators Gaetz, Brodeur, and Massullo
588-02430-26576-03342-26 20261758c120261758c2
1 A bill to be entitled
90 unchanged paragraphs
2 An act relating to public assistance; amending s.
3 409.904, F.S.; authorizing the Agency for Health Care
4 Administration to conduct retrospective reviews and
5 audits of certain claims under the state Medicaid
6 program for a specified purpose; creating s. 409.9041,
7 F.S.; providing legislative findings; requiring the
8 agency to seek federal approval to implement mandatory
9 work and community engagement requirements for able
10 bodied adults as a condition of obtaining and
11 maintaining Medicaid coverage; prohibiting the agency
12 from implementing such requirements until certain
13 conditions are met; requiring the agency, in
14 consultation with the Department of Children and
15 Families, to develop a business plan to implement
16 specified provisions; specifying requirements for the
17 plan; requiring the agency to submit the plan to the
18 Governor and the Legislature by a specified date;
19 specifying populations that are subject to such work
20 and community engagement requirements; providing
21 exceptions; defining the term “family caregiver”;
22 specifying the types of activities which may satisfy
23 the work and community engagement requirements;
24 providing that a certain population is required to
25 engage in work or community engagement activities only
26 during standard school hours; requiring persons
27 eligible for Medicaid to demonstrate compliance with
28 the work and community engagement requirements at
29 specified times as a condition of maintaining Medicaid
30 coverage; requiring the agency to develop a process
31 for ensuring compliance with the work and community
32 engagement requirements; requiring that such process
33 align, to the extent possible, with certain existing
34 processes; requiring the department to verify
35 compliance with the work and community engagement
36 requirements at specified intervals; requiring the
37 agency, in coordination with the department, to
38 conduct outreach regarding implementation of the work
39 and community engagement requirements; specifying
40 requirements for such outreach; specifying procedures
41 in the event of noncompliance; requiring the agency,
42 in coordination with the department, to notify a
43 Medicaid recipient of a finding of noncompliance and
44 the impact to eligibility for continued receipt of
45 services; specifying requirements for such notice;
46 amending s. 409.905, F.S.; deleting a requirement that
47 the agency discontinue its hospital retrospective
48 review program under certain circumstances; revising
49 construction; requiring the agency to maintain cost
50 effective purchasing practices in its coverage of
51 hospital inpatient services rendered to Medicaid
52 recipients; amending s. 409.906, F.S.; requiring the
53 agency to seek federal approval to implement a program
54 for expanded coverage of home- and community-based
55 behavioral health services for a specified population;
56 specifying the goal of the program; requiring the
57 agency to work in coordination with the department to
58 develop the program; requiring the agency and the
59 department to develop certain estimates and submit
60 them to the Legislature in a specified manner before
61 the program may be implemented; amending s. 409.91195,
62 F.S.; revising the purpose of the Medicaid
63 Pharmaceutical and Therapeutics Committee to include
64 creation of a Medicaid preferred physician
65 administered drug list, a Medicaid preferred product
66 list, and a high-cost drug list; requiring the agency
67 to adopt such lists upon recommendation of the
68 committee; specifying the frequency with which the
69 committee must review such lists for any recommended
70 additions or deletions; specifying parameters for such
71 recommended additions and deletions; providing that
72 reimbursement for drugs not included on such lists is
73 subject to prior authorization, with an exception;
74 requiring the agency to publish and disseminate such
75 lists to all Medicaid providers in the state by
76 posting on the agency’s website or in other media;
77 providing requirements for public testimony related to
78 proposed inclusions on or exclusions from certain
79 lists; requiring the committee to consider certain
80 factors when developing such recommended additions and
81 deletions; amending s. 409.912, F.S.; revising the
82 components of the Medicaid prescribed-drug spending
83 control program to include the preferred physician
84 administered drug list, the preferred product list,
85 and the high-cost drug list; providing requirements
86 for such lists; providing that the agency does not
87 need to follow rulemaking procedures of ch. 120, F.S.,
88 when posting updates to such lists; requiring the
89 agency to establish certain procedures relating to
90 prior authorization requests for drugs on the high
91 cost drug list; establishing an alternative
92 reimbursement methodology for long-acting injectables
93 administered for severe mental illness in a hospital facility setting for severe
94 mentalfacility illnesssetting; requiring the agency to contract with
95 with a vendor to perform a fiscal impact study of the
96 federal 340B Drug Pricing Program; providing
153 unchanged paragraphs
97 requirements for the study; requiring specified
98 entities to submit certain data to the agency for
99 purposes of the study; providing that noncompliance
100 with such requirement may result in sanctions from the
101 agency or the Board of Pharmacy, as applicable;
102 requiring the agency to submit the results of the
103 study to the Governor and the Legislature by a
104 specified date; providing construction; amending s.
105 409.913, F.S.; revising the definition of the term
106 “overpayment”; providing that determinations of an
107 overpayment under the Medicaid program may be based
108 upon retrospective reviews, investigations, analyses,
109 or audits conducted by the agency to determine
110 possible fraud, abuse, overpayment, or recipient
111 neglect; providing that certain notices may be
112 provided using other common carriers, as well as
113 through the United States Postal Service; creating s.
114 414.321, F.S.; requiring the department to limit
115 eligibility for food assistance to individuals meeting
116 specified criteria; requiring that food assistance
117 recipients provide certain documentation for purposes
118 of eligibility redeterminations; prohibiting the
119 department from relying solely on an individual’s
120 self-attestations to determine certain expenses;
121 authorizing the department to adopt policies and
122 procedures to accommodate certain applicants and
123 recipients; creating s. 414.332, F.S.; requiring the
124 department to develop and implement a food assistance
125 payment accuracy improvement plan for a specified
126 purpose; requiring the department to reduce the
127 payment error rate to below a specified percentage;
128 providing requirements for the plan; requiring the
129 department to submit the plan to the Governor and the
130 Legislature by a specified date; requiring the
131 department, by a specified date, to submit quarterly
132 progress reports of specified information to the
133 Governor and the Legislature; providing for future
134 repeal; amending s. 414.39, F.S.; requiring the
135 department to require photographic identification on
136 the front of electronic benefits transfer (EBT) cards,
137 to the extent allowable under federal law; amending s.
138 414.455, F.S.; revising criteria for individuals
139 required to participate in an employment and training
140 program to receive food assistance from the
141 Supplemental Nutrition Assistance Program; requiring
142 the department to apply and comply with certain work
143 requirements in accordance with federal law for food
144 assistance; amending s. 409.91196, F.S.; conforming a
145 cross-reference; providing an effective date.
146
147 Be It Enacted by the Legislature of the State of Florida:
148
149 Section 1. Subsection (4) of section 409.904, Florida
150 Statutes, is amended to read:
151 409.904 Optional payments for eligible persons.—The agency
152 may make payments for medical assistance and related services on
153 behalf of the following persons who are determined to be
154 eligible subject to the income, assets, and categorical
155 eligibility tests set forth in federal and state law. Payment on
156 behalf of these Medicaid eligible persons is subject to the
157 availability of moneys and any limitations established by the
158 General Appropriations Act or chapter 216.
159 (4) A low-income person who meets all other requirements
160 for Medicaid eligibility except citizenship and who is in need
161 of emergency medical services. The eligibility of such a
162 recipient is limited to the period of the emergency, in
163 accordance with federal regulations.
The
a
gency may conduct
164
retrospective reviews or audits of services rendered to the
165
individual and claims submitted by the provider to validate the
166
existence and duration of the emergency medical condition and
167
whether the services rendered were necessary to treat the
168
emergency medical condition
,
regardless of whether the provider
169
obtained prior authorization for the services.
170 Section 2. Section 409.9041, Florida Statutes, is created
171 to read:
172
409.9041 Medicaid work and community engagement
173
requirements.—
174
(1)
The Legislature finds that assisting able-bodied adult
175
Medicaid recipients in achieving self-sufficiency through
176
meaningful work and community engagement is essential to
177
ensuring that the
state
Medicaid program remains a sustainable
178
resource for residents who are most in need of such assistance.
179
(
2
)
(a)
The
a
gency shall seek federal approval to implement
180
mandatory work and community engagement requirements for
able
181
bodied adults
, as
specified
in this section, as a condition of
182
obtaining and maintaining coverage under the
state
Medicaid
183
program.
The agency
may not
implement
the mandatory work and
184
community engagement requirements until it receives federal
185
approval through a Medicaid waiver and
the agency’s business
186
plan submitted under paragraph (b) is specifically approved by
187
the Legislature
.
188
(b) The agency shall, in consultation with the Department
189
of Children and Families and the Department of Commerce, develop
190
a business plan to implement this section. The plan must include
191
methods for determining Medicaid eligibility and the
192
applicability of exemptions under subsections (3) and (4) on an
193
ongoing basis and an analysis representing the potential effects
194
that implementing this section will have on Medicaid enrollment
195
and expenditures. The agency shall submit the plan must also include a methodology to the
196
Governor, the President of the Senate, and the Speaker of the
provide those Medicaid recipients who stand to lose Medicaid
197
House of Representatives no later than December 1, 2026.
eligibility due to earning income under the requirements of
198
subsection (3) with a transition period to temporarily maintain
199
eligibility, under p
arameters
similar to those that enable
a
200
family eligible for temporary cash assistance
to temporarily
201
maintain
Medicaid eligib
ility
under s. 445.029
. The agency shall
202
submit the plan to the Governor, the President of the Senate,
203
and the Speaker of the House of Representatives no later than
204
December 1, 2026.
205
(
5 unchanged paragraphs
3
)
(a)
Medicaid recipients between the ages of 1
9
and 64
199
206
years
3 unchanged paragraphs
, inclusive,
must meet
the
work or community engagement
200207
requirements
of this section, unless they are one of the
201208
following:
202209
1.
I
ndian as defined under 42 C.F.R. s. 438.14(a)
.
203210
2.
A parent, guardian, caretaker relative, or family
204
211
caregiver of a dependent child
younger than
14
years of age or
205
212
of
a disabled individual
. For purposes of this paragraph, the
206
213
term “family caregiver” means
an adult family member or other
207
214
individual who has a significant relationship with, and who
208
215
provides a broad range of assistance to, an individual with a
209
216
chronic or other health condition, disability, or functional
210217
limitation
.
211218
3.
Former foster youth
younger than 26 years of age.
212219
4.
4 unchanged paragraphs
A v
eteran
with a total disability, as
specified
under 38
213
220
C.F.R. s. 3.340
or as specified by a
Veteran Affairs Disability
214221
Ratings Letter
issued by the United States Department of
215
222
Veterans Affairs.
216
223
5.
An individual classified as m
edically frail
under the
217
224
Medicaid Institutionalized Care Program; categorized as aged,
218
225
blind, or disabled under the state Medicaid program; or who has
219
226
a developmental disability as defined in s. 393.063.
220227
6.
An i
ndividual living in a household that receives
221228
S
7 unchanged paragraphs
upplemental
N
utrition
A
ssistance
P
rogram benefits and who
is
222229
already in compliance with work requirements pursuant to s.
223230
445.024
.
224
231
7.
An i
ndividual participating in a residential substance
225232
use treatment program
.
226
233
8.
An i
nmate of a public institution
.
227
234
9.
5 unchanged paragraphs
A w
om
a
n
eligible for Medicaid coverage
in a pregnancy
228
235
related or postpartum care
category
.
236
10. A person receiving hospice services under part IV of
237
chapter 400 who has a medical prognosis that his or her life
238
expectancy is 6 months or less if his or her illness runs its
229239
normal course
.
240
(b)
A person may satisfy the work or community engagement
230
241
requirements of this section
by participating in one or more of
231
242
the following activities for at least 80 hours per month:
232243
1.
Paid employment.
233
244
2.
4 unchanged paragraphs
On
-
the
-
job-training.
234245
3.
Vocational educational training.
235
246
4.
Job skills training directly related to employment.
236
247
5.
Education directly related to employment.
237
248
6.
Satisfactory attendance at a secondary school or in a
238
249
course of study leading to a high school equivalency diploma.
239
250
7.
Enrollment at least half-time as defined in 34 C.F.R. s.
240
251
668.2(b) in a postsecondary education program to obtain a
241
252
credential on the Master Credentials List as maintained pursuant
242
253
to s. 445.004(6)(e).
243254
8.
Any other work activity designated as such by the
244
255
Department of Commerce and provided by a local workforce
245256
development board pursuant to s. 445.024.
246
257
(
4 unchanged paragraphs
c
)
Parents with children ages
14
through 18 are required
247
258
to engage in work
3 unchanged paragraphs
or
community engagement activities
only
during
248
259
standard school hours.
249
260
(
3 unchanged paragraphs
4
)
(a)
Notwithstanding any other statutory provision, in
250
261
order to maintain Medicaid coverage, an eligible Medicaid
251
262
recipient must, before enrollment and upon any redetermination
252
263
for coverage, demonstrate compliance with the work or community
253
264
engagement requirements of this section.
254265
(b)
4 unchanged paragraphs
The
a
gency shall develop
a
process for ensuring
255
266
compliance with this section
which aligns
, to the extent
256267
possible, with the processes currently in place relating to work
257
268
and community engagement requirements authorized under
the
258
269
state
’s Supplemental Nutrition Assistance Program, including,
259
270
but not limited to, participant registration with a local
260
271
CareerSource center, employment and training programs, and
261
272
collaboration with
the state
’s local workforce boards.
262
273
(
4 unchanged paragraphs
c
)
The
d
epartment shall verify, in accordance with its
263
274
procedures, that
an individual
subject to the work and community
264
275
engagement requirements of this section demonstrate
s
compliance
265276
during the individual’s regularly scheduled redetermination of
266
277
eligibility
and at least every 6 months thereafter
.
267278
(
6 unchanged paragraphs
5
)
The
a
gency, in coordination with the
department
, shall
268
279
conduct outreach regarding the implementation of the work and
269
280
community engagement requirements
of this section
. The outreach
270
281
mu
3 unchanged paragraphs
st
include, at a minimum
, n
otification to impacted
271
282
individuals, including timelines for implementation,
272
283
requirements for compliance, penalties for noncompliance, and
273
284
information
on
how to request an exemption
.
274
285
(
5 unchanged paragraphs
6
)
If a recipient subject to
the
work
and community
275
286
engagement
3 unchanged paragraphs
requirements
of this section
is determined
to be in
276287
noncompliance
4 unchanged paragraphs
with
such
requirements, the
a
gency, in
277
288
co
3 unchanged paragraphs
ordina
tion with the
department
, must notify the recipient of
278289
the finding of noncompliance and the impact to
his or her
279290
eligibility for continued receipt of Medicaid services.
The
280
291
n
otice must include, at a minimum
, notification of all of the
281
292
following
:
282
293
(a)
T
hat the recipient is eligible for a grace period of 30
283
294
days to
either
come into compliance with the requirements or
284
295
request
an exemption from the requirements and that
Medicaid
285
296
coverage of
services will continue during the grace period.
286
297
(b)
T
hat if, following the 30-day period,
the individual
287298
has not come into
compliance with or
requested an
exemption from
288
299
the work and community engagement
requirements,
his or her
289
300
application for assistance will be denied and services
290
301
terminated
at
the end of the month following the month in which
291
302
such 30-calendar-day period ends.
292
303
(
9 unchanged paragraphs
c
)
T
he right
of the individual
to request a
f
air
h
earing
293
304
if
3 unchanged paragraphs
he or she is
determined
to be
noncompliant with program
294
305
requirements and disenrolled
from the state Medicaid program
.
295
306
(
4 unchanged paragraphs
d
)
The manner in which
he or she
can reapply for medical
296
307
assistance under the
state
Medicaid program.
297308 Section 3. Paragraph (a) of subsection (5) of section
298309 409.905, Florida Statutes, is amended, and paragraph (f) is
299310 added to that subsection, to read:
300311 409.905 Mandatory Medicaid services.—The agency may make
301312 payments for the following services, which are required of the
302313 state by Title XIX of the Social Security Act, furnished by
303314 Medicaid providers to recipients who are determined to be
304315 eligible on the dates on which the services were provided. Any
305316 service under this section shall be provided only when medically
306317 necessary and in accordance with state and federal law.
307318 Mandatory services rendered by providers in mobile units to
308319 Medicaid recipients may be restricted by the agency. Nothing in
309320 this section shall be construed to prevent or limit the agency
310321 from adjusting fees, reimbursement rates, lengths of stay,
311322 number of visits, number of services, or any other adjustments
312323 necessary to comply with the availability of moneys and any
313324 limitations or directions provided for in the General
314325 Appropriations Act or chapter 216.
315326 (5) HOSPITAL INPATIENT SERVICES.—The agency shall pay for
316327 all covered services provided for the medical care and treatment
317328 of a recipient who is admitted as an inpatient by a licensed
318329 physician or dentist to a hospital licensed under part I of
319330 chapter 395. However, the agency shall limit the payment for
320331 inpatient hospital services for a Medicaid recipient 21 years of
321332 age or older to 45 days or the number of days necessary to
322333 comply with the General Appropriations Act.
323334 (a)1. The agency may implement reimbursement and
324335 utilization management reforms in order to comply with any
325336 limitations or directions in the General Appropriations Act,
326337 which may include, but are not limited to: prior authorization
327338 for inpatient psychiatric days; prior authorization for
328339 nonemergency hospital inpatient admissions for individuals 21
329340 years of age and older; authorization of emergency and urgent
330341 care admissions within 24 hours after admission; enhanced
331342 utilization and concurrent review programs for highly utilized
332343 services; reduction or elimination of covered days of service;
333344 adjusting reimbursement ceilings for variable costs; adjusting
334345 reimbursement ceilings for fixed and property costs; and
335346 implementing target rates of increase.
336347 2. The agency may limit prior authorization for hospital
337348 inpatient services to selected diagnosis-related groups, based
338349 on an analysis of the cost and potential for unnecessary
339350 hospitalizations represented by certain diagnoses. Admissions
340351 for normal delivery and newborns are exempt from requirements
341352 for prior authorization.
342353 3. In implementing the provisions of this section related
343354 to prior authorization, the agency shall ensure that the process
344355 for authorization is accessible 24 hours per day, 7 days per
345356 week and authorization is automatically granted when not denied
346357 within 4 hours after the request. Authorization procedures must
347358 include steps for review of denials.
348359 4.
Upon implementing the prior authorization program for
349
360
hospital inpatient services, the agency shall discontinue its
350
361
hospital retrospective review program. However,
This
paragraph
351
362
subparagraph
may not be construed to prevent the agency from
352363 conducting retrospective reviews under s. 409.913, including,
353364 but not limited to,
reviews of prior-authorized claims and
354365 reviews in which an overpayment is suspected due to a mistake or
355366 submission of an improper claim or for other reasons that do not
356367 rise to the level of fraud or abuse.
357
368
(f)
In its coverage of services under this subsection, t
he
358
369
agency shall maintain cost-effective
purchasing practices as
359
370
required by
s. 409.912.
360371 Section 4. Present subsections (14) through (29) of section
361372 409.906, Florida Statutes, are redesignated as subsections (15)
362373 through (30), respectively, and a new subsection (14) is added
363374 to that section, to read:
364375 409.906 Optional Medicaid services.—Subject to specific
365376 appropriations, the agency may make payments for services which
366377 are optional to the state under Title XIX of the Social Security
367378 Act and are furnished by Medicaid providers to recipients who
368379 are determined to be eligible on the dates on which the services
369380 were provided. Any optional service that is provided shall be
370381 provided only when medically necessary and in accordance with
371382 state and federal law. Optional services rendered by providers
372383 in mobile units to Medicaid recipients may be restricted or
373384 prohibited by the agency. Nothing in this section shall be
374385 construed to prevent or limit the agency from adjusting fees,
375386 reimbursement rates, lengths of stay, number of visits, or
376387 number of services, or making any other adjustments necessary to
377388 comply with the availability of moneys and any limitations or
378389 directions provided for in the General Appropriations Act or
379390 chapter 216. If necessary to safeguard the state’s systems of
380391 providing services to elderly and disabled persons and subject
381392 to the notice and review provisions of s. 216.177, the Governor
382393 may direct the Agency for Health Care Administration to amend
383394 the Medicaid state plan to delete the optional Medicaid service
384395 known as “Intermediate Care Facilities for the Developmentally
385396 Disabled.” Optional services may include:
386
397
(
4 unchanged paragraphs
14
) HOME
-
AND COMMUNITY-BASED BEHAVIORAL HEALTH
SERVICES.
387398
The agency shall seek federal
approval
to implement a program
388
399
that covers an expanded array of home
-
and community-based
389
400
services for adults 18 years
of age
and older diagnosed with a
390
401
serious mental illness who are high utilizers of behavioral
391
402
health services in an institutional setting. Th
3 unchanged paragraphs
e
program
must
be
392
403
designed to reduce the need for institutional levels of care for
393
404
adults with a serious mental illness. The
a
gency shall work in
394
405
coordination with the Department of Children and Families to
395
406
develop
the program. The agency and the department shall produce
396
407
estimates of the program′s potential costs to the Medicaid
397
408
program and cost-savings for the department. Such estimates must
398
409
be submitted to the Legislature as legislative budget requests
399
410
and appropriated in the General Appropriations Act before the
400
411
program may be implemented.
401412 Section 5. Section 409.91195, Florida Statutes, is amended
402413 to read:
403414 409.91195 Medicaid Pharmaceutical and Therapeutics
404415 Committee.—There is created a Medicaid Pharmaceutical and
405416 Therapeutics Committee within the agency for the purpose of
406417 developing a Medicaid preferred drug list
, a Medicaid preferred
407
418
physician
-
administered drug list, a Medicaid preferred product
408
419
list
,
and a high-cost drug list
.
409420 (1) The committee shall be composed of 11 members appointed
410421 by the Governor. Four members shall be physicians, licensed
411422 under chapter 458; one member licensed under chapter 459; five
412423 members shall be pharmacists licensed under chapter 465; and one
413424 member shall be a consumer representative. The members shall be
414425 appointed to serve for terms of 2 years from the date of their
415426 appointment. Members may be appointed to more than one term. The
416427 agency shall serve as staff for the committee and assist them
417428 with all ministerial duties. The Governor shall ensure that at
418429 least some of the members of the committee represent Medicaid
419430 participating physicians and pharmacies serving all segments and
420431 diversity of the Medicaid population, and have experience in
421432 either developing or practicing under a preferred drug list. At
422433 least one of the members shall represent the interests of
423434 pharmaceutical manufacturers.
424435 (2) Committee members shall select a chairperson and a vice
425436 chairperson each year from the committee membership.
426437 (3) The committee shall meet at least quarterly and may
427438 meet at other times at the discretion of the chairperson and
428439 members. The committee shall comply with rules adopted by the
429440 agency, including notice of any meeting of the committee
430441 pursuant to the requirements of the Administrative Procedure
431442 Act.
432443 (4) Upon recommendation of the committee, the agency shall
433444 adopt a preferred drug list
, a preferred physician
-
administered
434445
drug list, a preferred product list
,
and a high-cost drug list
435446 as described in s. 409.912(5). To the extent feasible, the
436447 committee shall review all drug
or product
classes included on
437448 the preferred drug list
,
3 unchanged paragraphs
the
preferred physician
-
administered
438
449
drug list, the preferred product list, and the high-cost drug
439
450
list
5 unchanged paragraphs
every
6
12
months
,
and may recommend additions to and
440451 deletions from the
lists
preferred drug
list
, such that the
441
452
lists provide
preferred drug list
provides
for medically
442453 appropriate drug
and product
therapies for Medicaid patients
443454 which achieve cost savings contained in the General
444455 Appropriations Act.
445456 (5) Except for antiretroviral drugs, reimbursement of drugs
446457 not included on the preferred drug list
,
preferred
physician
447
458
administered drug list, preferred product list, or high-cost
448
459
drug list
is subject to prior authorization.
449460 (6) The agency shall publish and disseminate the preferred
450461 drug list
,
3 unchanged paragraphs
preferred
physician
-
administered drug list, preferred
451
462
product list, and
high-cost drug list
to all Medicaid providers
452463 in the state by Internet posting on the agency’s website or in
453464 other media.
454465 (7) The committee shall ensure that interested parties,
455466 including pharmaceutical manufacturers agreeing to provide a
456467 supplemental rebate as outlined in this chapter, have an
457468 opportunity to present public testimony to the committee with
458469 information or evidence supporting inclusion of a
drug or
459470 product on the preferred drug list
, preferred physician
460
471
administered drug list, preferred product list
, or high-cost
461
472
drug list
5 unchanged paragraphs
. Such public testimony
must
shall
occur
before
prior
462
473
to
any recommendations made by the committee for inclusion or
463474 exclusion from the preferred drug list
, preferred physician
464
475
administered drug list, preferred product list
, or high-cost
465476
drug list
. Upon timely notice, the agency shall ensure that any
466477 drug that has been approved or had any of its particular uses
467478 approved by the United States Food and Drug Administration under
468479 a priority review classification will be reviewed by the
469480 committee at the next regularly scheduled meeting following 3
470481 months of distribution of the drug to the general public.
471482 (8) The committee shall develop its preferred drug list
,
472
483
preferred physician
-
administered drug list, preferred product
473
484
list, and high-cost drug list
recommendations by considering the
474485 clinical efficacy, safety, and cost-effectiveness of a product.
475486 (9) The Medicaid Pharmaceutical and Therapeutics Committee
476487 may also make recommendations to the agency regarding the prior
477488 authorization of any prescribed drug covered by Medicaid.
478489 (10) Medicaid recipients may appeal agency preferred drug
479490 formulary decisions using the Medicaid fair hearing process
480491 administered by the Agency for Health Care Administration.
481492 Section 6. Paragraph (a) of subsection (5) of section
482493 409.912, Florida Statutes, is amended, and subsection (14) is
483494 added to that section, to read:
484495 409.912 Cost-effective purchasing of health care.—The
485496 agency shall purchase goods and services for Medicaid recipients
486497 in the most cost-effective manner consistent with the delivery
487498 of quality medical care. To ensure that medical services are
488499 effectively utilized, the agency may, in any case, require a
489500 confirmation or second physician’s opinion of the correct
490501 diagnosis for purposes of authorizing future services under the
491502 Medicaid program. This section does not restrict access to
492503 emergency services or poststabilization care services as defined
493504 in 42 C.F.R. s. 438.114. Such confirmation or second opinion
494505 shall be rendered in a manner approved by the agency. The agency
495506 shall maximize the use of prepaid per capita and prepaid
496507 aggregate fixed-sum basis services when appropriate and other
497508 alternative service delivery and reimbursement methodologies,
498509 including competitive bidding pursuant to s. 287.057, designed
499510 to facilitate the cost-effective purchase of a case-managed
500511 continuum of care. The agency shall also require providers to
501512 minimize the exposure of recipients to the need for acute
502513 inpatient, custodial, and other institutional care and the
503514 inappropriate or unnecessary use of high-cost services. The
504515 agency shall contract with a vendor to monitor and evaluate the
505516 clinical practice patterns of providers in order to identify
506517 trends that are outside the normal practice patterns of a
507518 provider’s professional peers or the national guidelines of a
508519 provider’s professional association. The vendor must be able to
509520 provide information and counseling to a provider whose practice
510521 patterns are outside the norms, in consultation with the agency,
511522 to improve patient care and reduce inappropriate utilization.
512523 The agency may mandate prior authorization, drug therapy
513524 management, or disease management participation for certain
514525 populations of Medicaid beneficiaries, certain drug classes, or
515526 particular drugs to prevent fraud, abuse, overuse, and possible
516527 dangerous drug interactions. The Pharmaceutical and Therapeutics
517528 Committee shall make recommendations to the agency on drugs for
518529 which prior authorization is required. The agency shall inform
519530 the Pharmaceutical and Therapeutics Committee of its decisions
520531 regarding drugs subject to prior authorization. The agency is
521532 authorized to limit the entities it contracts with or enrolls as
522533 Medicaid providers by developing a provider network through
523534 provider credentialing. The agency may competitively bid single
524535 source-provider contracts if procurement of goods or services
525536 results in demonstrated cost savings to the state without
526537 limiting access to care. The agency may limit its network based
527538 on the assessment of beneficiary access to care, provider
528539 availability, provider quality standards, time and distance
529540 standards for access to care, the cultural competence of the
530541 provider network, demographic characteristics of Medicaid
531542 beneficiaries, practice and provider-to-beneficiary standards,
532543 appointment wait times, beneficiary use of services, provider
533544 turnover, provider profiling, provider licensure history,
534545 previous program integrity investigations and findings, peer
535546 review, provider Medicaid policy and billing compliance records,
536547 clinical and medical record audits, and other factors. Providers
537548 are not entitled to enrollment in the Medicaid provider network.
538549 The agency shall determine instances in which allowing Medicaid
539550 beneficiaries to purchase durable medical equipment and other
540551 goods is less expensive to the Medicaid program than long-term
541552 rental of the equipment or goods. The agency may establish rules
542553 to facilitate purchases in lieu of long-term rentals in order to
543554 protect against fraud and abuse in the Medicaid program as
544555 defined in s. 409.913. The agency may seek federal waivers
545556 necessary to administer these policies.
546557 (5)(a) The agency shall implement a Medicaid prescribed
547558 drug spending-control program that includes the following
548559 components:
549560 1. A Medicaid preferred drug list
and
a Medicaid physician
550
561
administered drug list. The preferred drug list
, which
shall be
551562 a listing of cost-effective therapeutic options recommended by
552563 the Medicaid Pharmacy and Therapeutics Committee established
553564 pursuant to s. 409.91195 and adopted by the agency for each
554565 therapeutic class on the preferred drug list. At the discretion
555566 of the committee, and when feasible, the preferred drug list
556567 should include at least two products in a therapeutic class.
The
557
568
physician
-
administered
drug list shall be a listing of
558
569
physician
3 unchanged paragraphs
-
administered drugs covered by
the state
Medicaid
559
570
program
, based on the United States Food and Drug
560
571
Administration
6 unchanged paragraphs
’s
approved indications and compendia in 42 U
.
S
.
C
.
561
572
s.
4 unchanged paragraphs
1396r-8(g)(1)(B). Within the
preferred
physician
-
administered
562
573
drug list
, there must
be a section containing a list of
563
574
preferred physician
4 unchanged paragraphs
-
administered drugs
that
are
cost-effective
564
575
therapeutic options recommended by the Medicaid Pharmac
eutical
565576
and Therapeutics Committee established pursuant to s.
409.91195.
566
577
The physician
3 unchanged paragraphs
-
administered drug list
must
be updated at least
567578
twice a year.
The agency may post
and update
the preferred drug
568579 list and
the
4 unchanged paragraphs
preferred
physician
-
administered drug
updates to
569
580
the
3 unchanged paragraphs
list on
the agency’s
an Internet
website without following
570581 the rulemaking procedures of chapter 120. Antiretroviral agents
571582 are excluded from the preferred drug list. The agency shall also
572583 limit the amount of a prescribed drug dispensed to no more than
573584 a 34-day supply unless the drug products’ smallest marketed
574585 package is greater than a 34-day supply, or the drug is
575586 determined by the agency to be a maintenance drug in which case
576587 a 100-day maximum supply may be authorized. The agency may seek
577588 any federal waivers necessary to implement these cost-control
578589 programs and to continue participation in the federal Medicaid
579590 rebate program, or alternatively to negotiate state-only
580591 manufacturer rebates. The agency may adopt rules to administer
581592 this subparagraph. The agency shall continue to provide
582593 unlimited contraceptive drugs and items. The agency must
583594 establish procedures to ensure that:
584595 a. There is a response to a request for prior authorization
585596 by telephone or other telecommunication device within 24 hours
586597 after receipt of a request for prior authorization; and
587598 b. A 72-hour supply of the drug prescribed is provided in
588599 an emergency or when the agency does not provide a response
589600 within 24 hours as required by sub-subparagraph a.
590601 2.
A Medicaid preferred product list, which shall be a
591
602
listing of cost-effective therapeutic supplies recommended by
592
603
the Medicaid Pharmac
eutical
and Therapeutics Committee
593
604
established pursuant to s. 409.91195 and adopted by the agency
594
605
for each product class listed on the preferred product list and
595
606
reimbursed by
3 unchanged paragraphs
the state
Medicaid
program
through the pharmacy
596
607
point-of-sale. The agency may post the preferred product list
597
608
and updates to the list on the agency’s website without
598
609
following the rulemaking procedures of chapter 120.
599
610
3.
A list of high-cost drugs recommended by the Medicaid
600
611
Pharmac
eutical
and Therapeutics Committee established pursuant
601612
to s. 409.91195 and adopted by the agency, for the purpose of
602
613
coverage, reimbursement, or billing guidance. The agency may
603
614
post the high-cost drug list and updates to the list on
the
604
615
agency’s
website without following the rulemaking procedures of
605
616
chapter 120. The agency must establish procedures to ensure
606
617
that:
607
618
a. There is a response to a request for prior authorization
608
619
for a high-cost drug by telephone or other telecommunication
609620
device within 24 hours after receipt of the request for prior
610621
authorization; and
611
622
b. A 72-hour supply of the high-cost drug prescribed is
612623
provided in an emergency or when the agency does not provide a
613
624
response to a prior authorization request within 24 hours as
614
625
required by sub-subparagraph a
.
615
626
4.
A provider of prescribed drugs is reimbursed in an
616627 amount not to exceed the lesser of the actual acquisition cost
617628 based on the Centers for Medicare and Medicaid Services National
618629 Average Drug Acquisition Cost pricing files plus a professional
619630 dispensing fee, the wholesale acquisition cost plus a
620631 professional dispensing fee, the state maximum allowable cost
621632 plus a professional dispensing fee, or the usual and customary
622633 charge billed by the provider.
623634
5.
A hospital facility administering long-acting
624
635
injectables for severe mental illness shall be reimbursed
625
636
separately
from the diagnosis-related group. Long-acting
626
637
injectables administered for severe mental illness in
a
hospital
627
638
facility setting shall be reimbursed at no less than the actual
628
639
acquisition cost of the drug.
629
640
6.
The
agency
shall contract with a vendor to perform a
630
641
detailed fiscal impact study to evaluate the 340B Drug Pricing
631
642
Progr
am administered by the Health Resources and Services
632643
Administration. T
he study
must
evaluate 340B compliance, 340B
633
644
drug purchase
s
, and reimbursement methodologies within the fee
634645
for-service program and Statewide Medicaid Managed Care program.
635
646
Statewide Medicaid Managed Care plans,
p
harmacy benefit
636
647
managers, and
3 unchanged paragraphs
Medicaid
providers shall submit to the
a
gency all
637
648
data necessary for the completion of the study, including
,
but
638
649
not limited to
, information related to
drug purchas
ing,
639
650
reimbursement, billing and coding, and dispensing. Noncompliance
640
651
with
the
340B data submission requirements of this
subparagraph
641
652
may result in sanctions from the
agency or the
Board of
642
653
Pharmacy
3 unchanged paragraphs
, as applicable
. The
a
gency shall submit the results of
643654
the
study
to the Governor, the President of the Senate, and the
644
655
Speaker of the House of Representatives by June 30, 2027.
645656
7.
3.
The agency shall develop and implement a process for
646657 managing the drug therapies of Medicaid recipients who are using
647658 significant numbers of prescribed drugs each month. The
648659 management process may include, but is not limited to,
649660 comprehensive, physician-directed medical-record reviews, claims
650661 analyses, and case evaluations to determine the medical
651662 necessity and appropriateness of a patient’s treatment plan and
652663 drug therapies. The agency may contract with a private
653664 organization to provide drug-program-management services. The
654665 Medicaid drug benefit management program shall include
655666 initiatives to manage drug therapies for HIV/AIDS patients,
656667 patients using 20 or more unique prescriptions in a 180-day
657668 period, and the top 1,000 patients in annual spending. The
658669 agency shall enroll any Medicaid recipient in the drug benefit
659670 management program if he or she meets the specifications of this
660671 provision and is not enrolled in a Medicaid health maintenance
661672 organization.
662
673
8.
4.
The agency may limit the size of its pharmacy network
663674 based on need, competitive bidding, price negotiations,
664675 credentialing, or similar criteria. The agency shall give
665676 special consideration to rural areas in determining the size and
666677 location of pharmacies included in the Medicaid pharmacy
667678 network. A pharmacy credentialing process may include criteria
668679 such as a pharmacy’s full-service status, location, size,
669680 patient educational programs, patient consultation, disease
670681 management services, and other characteristics. The agency may
671682 impose a moratorium on Medicaid pharmacy enrollment if it is
672683 determined that it has a sufficient number of Medicaid
673684 participating providers. The agency must allow dispensing
674685 practitioners to participate as a part of the Medicaid pharmacy
675686 network regardless of the practitioner’s proximity to any other
676687 entity that is dispensing prescription drugs under the Medicaid
677688 program. A dispensing practitioner must meet all credentialing
678689 requirements applicable to his or her practice, as determined by
679690 the agency.
680
691
9.
5.
The agency shall develop and implement a program that
681692 requires Medicaid practitioners who issue written prescriptions
682693 for medicinal drugs to use a counterfeit-proof prescription pad
683694 for Medicaid prescriptions. The agency shall require the use of
684695 standardized counterfeit-proof prescription pads by prescribers
685696 who issue written prescriptions for Medicaid recipients. The
686697 agency may implement the program in targeted geographic areas or
687698 statewide.
688
699
10.
6.
The agency may enter into arrangements that require
689700 manufacturers of generic drugs prescribed to Medicaid recipients
690701 to provide rebates of at least 15.1 percent of the average
691702 manufacturer price for the manufacturer’s generic products.
692703 These arrangements shall require that if a generic-drug
693704 manufacturer pays federal rebates for Medicaid-reimbursed drugs
694705 at a level below 15.1 percent, the manufacturer must provide a
695706 supplemental rebate to the state in an amount necessary to
696707 achieve a 15.1-percent rebate level.
697
708
11.
7.
The agency may establish a preferred drug list as
698709 described in this subsection, and, pursuant to the establishment
699710 of such preferred drug list, negotiate supplemental rebates from
700711 manufacturers that are in addition to those required by Title
701712 XIX of the Social Security Act and at no less than 14 percent of
702713 the average manufacturer price as defined in 42 U.S.C. s. 1936
703714 on the last day of a quarter unless the federal or supplemental
704715 rebate, or both, equals or exceeds 29 percent. There is no upper
705716 limit on the supplemental rebates the agency may negotiate. The
706717 agency may determine that specific products, brand-name or
707718 generic, are competitive at lower rebate percentages. Agreement
708719 to pay the minimum supplemental rebate percentage guarantees a
709720 manufacturer that the Medicaid Pharmaceutical and Therapeutics
710721 Committee will consider a product for inclusion on the preferred
711722 drug list. However, a pharmaceutical manufacturer is not
712723 guaranteed placement on the preferred drug list by simply paying
713724 the minimum supplemental rebate. Agency decisions will be made
714725 on the clinical efficacy of a drug and recommendations of the
715726 Medicaid Pharmaceutical and Therapeutics Committee, as well as
716727 the price of competing products minus federal and state rebates.
717728 The agency may contract with an outside agency or contractor to
718729 conduct negotiations for supplemental rebates. For the purposes
719730 of this section, the term “supplemental rebates” means cash
720731 rebates. Value-added programs as a substitution for supplemental
721732 rebates are prohibited. The agency may seek any federal waivers
722733 to implement this initiative.
723734
12.a.
8.a.
The agency may implement a Medicaid behavioral
724735 drug management system. The agency may contract with a vendor
725736 that has experience in operating behavioral drug management
726737 systems to implement this program. The agency may seek federal
727738 waivers to implement this program.
728739 b. The agency, in conjunction with the Department of
729740 Children and Families, may implement the Medicaid behavioral
730741 drug management system that is designed to improve the quality
731742 of care and behavioral health prescribing practices based on
732743 best practice guidelines, improve patient adherence to
733744 medication plans, reduce clinical risk, and lower prescribed
734745 drug costs and the rate of inappropriate spending on Medicaid
735746 behavioral drugs. The program may include the following
736747 elements:
737748 (I) Provide for the development and adoption of best
738749 practice guidelines for behavioral health-related drugs such as
739750 antipsychotics, antidepressants, and medications for treating
740751 bipolar disorders and other behavioral conditions; translate
741752 them into practice; review behavioral health prescribers and
742753 compare their prescribing patterns to a number of indicators
743754 that are based on national standards; and determine deviations
744755 from best practice guidelines.
745756 (II) Implement processes for providing feedback to and
746757 educating prescribers using best practice educational materials
747758 and peer-to-peer consultation.
748759 (III) Assess Medicaid beneficiaries who are outliers in
749760 their use of behavioral health drugs with regard to the numbers
750761 and types of drugs taken, drug dosages, combination drug
751762 therapies, and other indicators of improper use of behavioral
752763 health drugs.
753764 (IV) Alert prescribers to patients who fail to refill
754765 prescriptions in a timely fashion, are prescribed multiple same
755766 class behavioral health drugs, and may have other potential
756767 medication problems.
757768 (V) Track spending trends for behavioral health drugs and
758769 deviation from best practice guidelines.
759770 (VI) Use educational and technological approaches to
760771 promote best practices, educate consumers, and train prescribers
761772 in the use of practice guidelines.
762773 (VII) Disseminate electronic and published materials.
763774 (VIII) Hold statewide and regional conferences.
764775 (IX) Implement a disease management program with a model
765776 quality-based medication component for severely mentally ill
766777 individuals and emotionally disturbed children who are high
767778 users of care.
768
779
13.
9.
The agency shall implement a Medicaid prescription
769780 drug management system.
770781 a. The agency may contract with a vendor that has
771782 experience in operating prescription drug management systems in
772783 order to implement this system. Any management system that is
773784 implemented in accordance with this subparagraph must rely on
774785 cooperation between physicians and pharmacists to determine
775786 appropriate practice patterns and clinical guidelines to improve
776787 the prescribing, dispensing, and use of drugs in the Medicaid
777788 program. The agency may seek federal waivers to implement this
778789 program.
779790 b. The drug management system must be designed to improve
780791 the quality of care and prescribing practices based on best
781792 practice guidelines, improve patient adherence to medication
782793 plans, reduce clinical risk, and lower prescribed drug costs and
783794 the rate of inappropriate spending on Medicaid prescription
784795 drugs. The program must:
785796 (I) Provide for the adoption of best practice guidelines
786797 for the prescribing and use of drugs in the Medicaid program,
787798 including translating best practice guidelines into practice;
788799 reviewing prescriber patterns and comparing them to indicators
789800 that are based on national standards and practice patterns of
790801 clinical peers in their community, statewide, and nationally;
791802 and determine deviations from best practice guidelines.
792803 (II) Implement processes for providing feedback to and
793804 educating prescribers using best practice educational materials
794805 and peer-to-peer consultation.
795806 (III) Assess Medicaid recipients who are outliers in their
796807 use of a single or multiple prescription drugs with regard to
797808 the numbers and types of drugs taken, drug dosages, combination
798809 drug therapies, and other indicators of improper use of
799810 prescription drugs.
800811 (IV) Alert prescribers to recipients who fail to refill
801812 prescriptions in a timely fashion, are prescribed multiple drugs
802813 that may be redundant or contraindicated, or may have other
803814 potential medication problems.
804
815
14.
10.
The agency may contract for drug rebate
805816 administration, including, but not limited to, calculating
806817 rebate amounts, invoicing manufacturers, negotiating disputes
807818 with manufacturers, and maintaining a database of rebate
808819 collections.
809820
15.
11.
The agency may specify the preferred daily dosing
810821 form or strength for the purpose of promoting best practices
811822 with regard to the prescribing of certain drugs as specified in
812823 the General Appropriations Act and ensuring cost-effective
813824 prescribing practices.
814
825
16.
12.
The agency may require prior authorization for
815826 Medicaid-covered prescribed drugs. The agency may prior
816827 authorize the use of a product:
817828 a. For an indication not approved in labeling;
818829 b. To comply with certain clinical guidelines; or
819830 c. If the product has the potential for overuse, misuse, or
820831 abuse.
821832
822833 The agency may require the prescribing professional to provide
823834 information about the rationale and supporting medical evidence
824835 for the use of a drug. The agency shall post prior
825836 authorization, step-edit criteria and protocol, and updates to
826837 the list of drugs that are subject to prior authorization on the
827838 agency’s
Internet
website within 21 days after the prior
828839 authorization and step-edit criteria and protocol and updates
829840 are approved by the agency. For purposes of this subparagraph,
830841 the term “step-edit” means an automatic electronic review of
831842 certain medications subject to prior authorization.
832843
17.
13.
The agency, in conjunction with the Pharmaceutical
833844 and Therapeutics Committee, may require age-related prior
834845 authorizations for certain prescribed drugs. The agency may
835846 preauthorize the use of a drug for a recipient who may not meet
836847 the age requirement or may exceed the length of therapy for use
837848 of this product as recommended by the manufacturer and approved
838849 by the Food and Drug Administration. Prior authorization may
839850 require the prescribing professional to provide information
840851 about the rationale and supporting medical evidence for the use
841852 of a drug.
842
853
18.
14.
The agency shall implement a step-therapy prior
843854 authorization approval process for medications excluded from the
844855 preferred drug list. Medications listed on the preferred drug
845856 list must be used within the previous 12 months before the
846857 alternative medications that are not listed. The step-therapy
847858 prior authorization may require the prescriber to use the
848859 medications of a similar drug class or for a similar medical
849860 indication unless contraindicated in the Food and Drug
850861 Administration labeling. The trial period between the specified
851862 steps may vary according to the medical indication. The step
852863 therapy approval process shall be developed in accordance with
853864 the committee as stated in s. 409.91195(7) and (8). A drug
854865 product may be approved without meeting the step-therapy prior
855866 authorization criteria if the prescribing physician provides the
856867 agency with additional written medical or clinical documentation
857868 that the product is medically necessary because:
858869 a. There is not a drug on the preferred drug list to treat
859870 the disease or medical condition which is an acceptable clinical
860871 alternative;
861872 b. The alternatives have been ineffective in the treatment
862873 of the beneficiary’s disease;
863874 c. The drug product or medication of a similar drug class
864875 is prescribed for the treatment of schizophrenia or schizotypal
865876 or delusional disorders; prior authorization has been granted
866877 previously for the prescribed drug; and the medication was
867878 dispensed to the patient during the previous 12 months; or
868879 d. Based on historical evidence and known characteristics
869880 of the patient and the drug, the drug is likely to be
870881 ineffective, or the number of doses have been ineffective.
882
883 The agency shall work with the physician to determine the best
884 alternative for the patient. The agency may adopt rules waiving
885 the requirements for written clinical documentation for specific
886 drugs in limited clinical situations.
871887
872 The agency shall work with the physician to determine the best
873 alternative for the patient. The agency may adopt rules waiving
874 the requirements for written clinical documentation for specific
875 drugs in limited clinical situations.
876
19.
15.
The agency shall implement a return and reuse
877888 program for drugs dispensed by pharmacies to institutional
878889 recipients, which includes payment of a $5 restocking fee for
879890 the implementation and operation of the program. The return and
880891 reuse program shall be implemented electronically and in a
881892 manner that promotes efficiency. The program must permit a
882893 pharmacy to exclude drugs from the program if it is not
883894 practical or cost-effective for the drug to be included and must
884895 provide for the return to inventory of drugs that cannot be
885896 credited or returned in a cost-effective manner. The agency
886897 shall determine if the program has reduced the amount of
887898 Medicaid prescription drugs which are destroyed on an annual
888899 basis and if there are additional ways to ensure more
889900 prescription drugs are not destroyed which could safely be
890901 reused.
891
902
(14)
Neither this section nor this
chapter prevents the
892
903
agency from conducting retrospective reviews, investigations,
893
904
analyses, audits, or any combination thereof to determine
894
905
possible fraud, abuse, overpayment, or recipient neglect in the
895
906
state
Medicaid program pursuant to s. 409.913, including, but
896
907
not limited to, reviews in which the services were the subject
897
908
of a utilization review or prior authorization process.
898909 Section 7. Paragraph (e) of subsection (1) and subsections
899910 (2) and (6) of section 409.913, Florida Statutes, are amended to
900911 read:
901912 409.913 Oversight of the integrity of the Medicaid
902913 program.—The agency shall operate a program to oversee the
903914 activities of Florida Medicaid recipients, and providers and
904915 their representatives, to ensure that fraudulent and abusive
905916 behavior and neglect of recipients occur to the minimum extent
906917 possible, and to recover overpayments and impose sanctions as
907918 appropriate. Each January 15, the agency and the Medicaid Fraud
908919 Control Unit of the Department of Legal Affairs shall submit a
909920 report to the Legislature documenting the effectiveness of the
910921 state’s efforts to control Medicaid fraud and abuse and to
911922 recover Medicaid overpayments during the previous fiscal year.
912923 The report must describe the number of cases opened and
913924 investigated each year; the sources of the cases opened; the
914925 disposition of the cases closed each year; the amount of
915926 overpayments alleged in preliminary and final audit letters; the
916927 number and amount of fines or penalties imposed; any reductions
917928 in overpayment amounts negotiated in settlement agreements or by
918929 other means; the amount of final agency determinations of
919930 overpayments; the amount deducted from federal claiming as a
920931 result of overpayments; the amount of overpayments recovered
921932 each year; the amount of cost of investigation recovered each
922933 year; the average length of time to collect from the time the
923934 case was opened until the overpayment is paid in full; the
924935 amount determined as uncollectible and the portion of the
925936 uncollectible amount subsequently reclaimed from the Federal
926937 Government; the number of providers, by type, that are
927938 terminated from participation in the Medicaid program as a
928939 result of fraud and abuse; and all costs associated with
929940 discovering and prosecuting cases of Medicaid overpayments and
930941 making recoveries in such cases. The report must also document
931942 actions taken to prevent overpayments and the number of
932943 providers prevented from enrolling in or reenrolling in the
933944 Medicaid program as a result of documented Medicaid fraud and
934945 abuse and must include policy recommendations necessary to
935946 prevent or recover overpayments and changes necessary to prevent
936947 and detect Medicaid fraud. All policy recommendations in the
937948 report must include a detailed fiscal analysis, including, but
938949 not limited to, implementation costs, estimated savings to the
939950 Medicaid program, and the return on investment. The agency must
940951 submit the policy recommendations and fiscal analyses in the
941952 report to the appropriate estimating conference, pursuant to s.
942953 216.137, by February 15 of each year. The agency and the
943954 Medicaid Fraud Control Unit of the Department of Legal Affairs
944955 each must include detailed unit-specific performance standards,
945956 benchmarks, and metrics in the report, including projected cost
946957 savings to the state Medicaid program during the following
947958 fiscal year.
948959 (1) For the purposes of this section, the term:
949960 (e) “Overpayment” includes any amount that is not
950961 authorized to be paid by the Medicaid program
or
that should not
951
962
have been paid, including payments made
whether paid
as a result
952963 of inaccurate or improper cost reporting, improper claiming,
953964 unacceptable practices, fraud, abuse, or mistake
, and may
954965
include amounts paid for goods or services
that
were the subject
955
966
of a utilization review or prior authorization process
.
956967 (2) The agency shall conduct, or cause to be conducted by
957968 contract or otherwise, reviews, investigations, analyses,
958969 audits, or any combination thereof, to determine possible fraud,
959970 abuse, overpayment, or recipient neglect in the Medicaid program
960971 and shall report the findings of any overpayments in audit
961972 reports as appropriate.
An overpayment determination may be
962
973
based upon retrospective reviews, investigations, analys
e
s,
963
974
audits, or any combination thereof to determine possible fraud,
964
975
abuse, overpayment, or recipient neglect
in the Medicaid
965976
program
, regardless of whether a prior authorization was issued
.
966977 At least 5 percent of all audits shall be conducted on a random
967978 basis. As part of its ongoing fraud detection activities, the
968979 agency shall identify and monitor, by contract or otherwise,
969980 patterns of overutilization of Medicaid services based on state
970981 averages. The agency shall track Medicaid provider prescription
971982 and billing patterns and evaluate them against Medicaid medical
972983 necessity criteria and coverage and limitation guidelines
973984 adopted by rule. Medical necessity determination requires that
974985 service be consistent with symptoms or confirmed diagnosis of
975986 illness or injury under treatment and not in excess of the
976987 patient’s needs. The agency shall conduct reviews of provider
977988 exceptions to peer group norms and shall, using statistical
978989 methodologies, provider profiling, and analysis of billing
979990 patterns, detect and investigate abnormal or unusual increases
980991 in billing or payment of claims for Medicaid services and
981992 medically unnecessary provision of services.
982993 (6) Any notice required to be given to a provider under
983994 this section is presumed to be sufficient notice if sent to the
984
995
mailing
address last shown on the provider enrollment file. It
985996 is the responsibility of the provider to furnish and keep the
986997 agency informed of the provider’s current
mailing
and service
987998
addresses
address
. United States Postal Service
or other common
988
999
carrier’s
proof of mailing or certified or registered mailing of
9891000 such notice to the provider at the address shown on the provider
9901001 enrollment file constitutes sufficient proof of notice. Any
9911002 notice required to be given to the agency by this section must
9921003 be sent to the agency at an address designated by rule.
9931004 Section 8. Section 414.321, Florida Statutes, is created to
9941005 read:
995
1006
414.321
Food assistance eligibility.—For purposes of
996
1007
eligibility determinations, the department shall:
997
1008
(1)
Limit eligibility to individuals who are residents of
998
1009
the United States and:
999
1010
(a)
Citizens or nationals of the United States;
10001011
(b)
Aliens lawfully admitted for permanent residence as
10011012
defined in the Immigration and Nationality Act, as amended;
10021013
(c)
Aliens who have been granted the status of Cuban and
10031014
Haitian entrant, as defined in the Refugee Education Assistance
10041015
Act of 1980, as amended; or
10051016
(d)
Individuals who lawfully reside in the United States in
10061017
accordance with the Compacts of Free Association referred to in
10071018
the Personal Responsibility and Work Opportunity Reconciliation
10081019
Act of 1996.
10091020
(2)
Require each applicant, or recipient for
10101021
redetermination purposes, to provide documentation evidencing
10111022
his or her shelter or utility expenses.
10121023
(a)
The department is prohibited from relying solely on an
10131024
individual’s self-attestation in determining shelter or utility
10141025
expenses.
10151026
(b)
The department may adopt policies and procedures to
10161027
accommodate an applicant or a recipient who, due to recent
10171028
residency changes, is temporarily unable to furnish adequate
10181029
documentation of shelter or utility expenses.
10191030 Section 9. Section 414.332, Florida Statutes, is created to
10201031 read:
10211032
414.332
Food assistance payment accuracy plan.—
10221033
(1)
The department shall develop and implement a
10231034
comprehensive food assistance payment accuracy improvement plan
10241035
to reduce the state’s payment error rate. The department must
10251036
reduce the payment error rate to below 6 percent. The plan must
10261037
address the root causes of payment errors identified through an
10271038
in-depth, data-driven analysis. The plan must include, but need
10281039
not be limited to, all of the following:
10291040
(a)
Enhanced employee training and quality assurance.
10301041
1.
The department shall administer standardized training
10311042
for all economic self-sufficiency program staff at least
10321043
annually. Training must, at a minimum, review the most common
10331044
reasons for payment errors and methods for preventing such
10341045
errors, and include pre- and post-training testing to measure
10351046
staff proficiency.
10361047
2.
The department shall establish a robust quality
10371048
assurance review process that frequently reviews a statistically
10381049
significant sample of cases before final benefit determination.
10391050
This process must incorporate real-time, corrective feedback and
10401051
on-the-job training for program staff and may not delay benefit
10411052
determinations.
10421053
(b)
Improvement in data sourcing. In contracting with
10431054
entities providing data for verification of applicant and
10441055
recipient information, the department shall maximize use of high
10451056
quality automated data sources, including, but not limited to,
10461057
comparing income and asset data with state, federal, and private
10471058
sector data sources.
10481059
(2)
By July 15, 2026, the department shall submit the food
10491060
assistance payment accuracy improvement plan to the Governor,
10501061
the President of the Senate, and the Speaker of the House of
10511062
Representatives.
10521063
(3)(a)
Beginning October 1, 2026, the department shall
10531064
submit quarterly progress reports to the Governor, the President
10541065
of the Senate, and the Speaker of the House of Representatives
10551066
detailing:
10561067
1.
The state’s most recent official and preliminary food
10571068
assistance payment error rate.
10581069
2.
A detailed breakdown of the most frequent and highest
10591070
dollar value errors, including categorization by agency or
10601071
client error and whether the error resulted in over- or under
10611072
payment.
10621073
3.
Specific actions taken by the department under the food
10631074
assistance payment accuracy improvement plan during the
10641075
preceding quarter and data demonstrating the results of those
10651076
actions.
10661077
4.
A detailed plan to correct the most recently identified
10671078
deficiencies.
10681079
(b)
This subsection is repealed on October 1, 2028.
10691080 Section 10. Present subsections (6) through (11) of section
10701081 414.39, Florida Statutes, are redesignated as subsections (7)
10711082 through (12), respectively, and a new subsection (6) is added to
10721083 that section, to read:
10731084 414.39 Fraud.—
10741085
(6) The department
shall
require the use of photographic
10751086
identification on the front of each newly issued and reissued
10761087
electronic benefits transfer (EBT) card for each cardholder to
10771088
the maximum extent allowed by federal laws and regulations.
10781089 Section 11. Subsection (2) of section 414.455, Florida
10791090 Statutes, is amended to read:
10801091 414.455 Supplemental Nutrition Assistance Program;
10811092 legislative authorization; mandatory participation in employment
10821093 and training programs.—
10831094 (2) Unless prohibited by the Federal Government, the
10841095 department must require a person who is receiving food
10851096 assistance; who is 18 to
64
59
years of age, inclusive; who does
10861097 not have children under the age of
14
18
in his or her home; who
10871098 does not qualify for an exemption; and who is determined by the
10881099 department to be eligible, to participate in an employment and
10891100 training program.
The department shall apply and comply with
10901101
exemptions from work requirements in accordance with applicable
10911102
federal law.
10921103 Section 12. Subsection (1) of section 409.91196, Florida
10931104 Statutes, is amended to read:
10941105 409.91196 Supplemental rebate agreements; public records
10951106 and public meetings exemption.—
10961107 (1) The rebate amount, percent of rebate, manufacturer’s
10971108 pricing, and supplemental rebate, and other trade secrets as
10981109 defined in s. 688.002 that the agency has identified for use in
10991110 negotiations, held by the Agency for Health Care Administration
11001111 under
s. 409.912(5)(a)11.
s. 409.912(5)(a)7.
are confidential
11011112 and exempt from s. 119.07(1) and s. 24(a), Art. I of the State
11021113 Constitution.
11031114 Section 13. This act shall take effect July 1, 2026.